Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860340 · ClinicalTrials.gov registry record · NA
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
A NA study of Congestive Heart Failure, sponsored by University of Toledo Health Science Campus.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00860340: Completed NA study of Congestive Heart Failure, sponsored by University of Toledo Health Science Campus.
NCT00860340 is a NA study of Congestive Heart Failure that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 18 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00860340, a NA study of Congestive Heart Failure, has completed, sponsored by University of Toledo Health Science Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if the beneficial effect of spironolactone in patients with congestive heart failure is in part due to its intrinsic inotropic action. Randomized, two group placebo controlled, single blind study.
Conditions Studied
Interventions
- DRUG Spironolactone
Study Locations (1)
Ohio
- Medical University of Ohio - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-10 |
| Phase | NA |
What the finished NCT00860340 record still lists
NCT00860340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Spironolactone is the first listed.
NCT00860340 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00860340 about?
NCT00860340 is a clinical study titled "Hemodynamic Effects of Spironolactone in Patients With Heart Failure". To determine if the beneficial effect of spironolactone in patients with congestive heart failure is in part due to its intrinsic inotropic action. Randomized, two group placebo controlled, single blind study.
What is the current status of trial NCT00860340?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2003-02. Estimated completion is 2006-10.
What conditions does trial NCT00860340 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT00860340?
The interventions under investigation include: Spironolactone (DRUG).
Who is sponsoring clinical trial NCT00860340?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00860340 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00860340's enrollment target sits among peer trials
18 47th of 51 higher than 5 of 51 other Congestive Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congestive Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia